Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1041205-43-9FC(F)n1cc(I)cn1VMZIHPOJBPKGDR-UHFFFAOYSA-N1041205-43-9DTXSID30728306Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H227 (50%): Combustible liquid [Warning Flammable liquids];H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P210, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Verwenden1-(Difluoromethyl)-4-iodo-1H-pyrazole is used in the preparation of pyrazole compounds as IRAK inhibitors for treating autoimmune diseases, inflammatory diseases and cancer
Wird geladen…